Role of GLP1 RA Dulaglutide on Severe Intracranial Atherosclerosis

Abroad (travel likely)RecruitingPHASE2, PHASE3

Conditions

Intracranial Atherosclerosis · Stroke, Ischemic

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

National University Hospital, Singapore, Singapore
Contact: Study coordinator (vijay K sharma, MD) · mdcvks@nus.edu.sg · 91389555

Study leads

vijay K sharma, MD
Principal Investigator
National University of Singapore

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Drug Eluting Stenting and Aggressive Medical Treatment for Preventing Recurrent Stroke in Intracranial Atherosclerotic Disease Trial

ICAD - Intracranial Atherosclerotic Disease · ICAS - Intracranial Atherosclerosis · Drug-eluting Stent

Abroad (travel likely)Recruiting

Beijing, China · Beijing, China

IntraCranial Atherosclerosis Related Large-vessel Occlusion Treated With Urgent Stenting (ICARUS)

Stroke · Stroke, Acute Ischemic · Intracranial Atherosclerosis

Abroad (travel likely)Recruiting

Basel, Switzerland

High-resolution Magnetic Resonance Imaging of Intracranial Atherosclerotic Plaques in Ischemic Stroke

Stroke · Intracranial Atherosclerosis · High Resolution Magnetic Resonance Imaging

Abroad (travel likely)Recruiting

Shenyang, China

PCSK9 Inhibitor With Statin Therapy for Asymptomatic Intracranial Atherosclerosis

Intracranial Atherosclerosis · Intracranial Artery Stenosis · Atherosclerotic Plaque

Abroad (travel likely)RecruitingPHASE4

Beijing, China · Beijing, China